What is the recommended management of dengue shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Dengue Shock Syndrome

For dengue shock syndrome, initiate resuscitation with crystalloid solutions (Ringer's lactate or normal saline) at 20 mL/kg boluses, with frequent reassessment after each bolus, and reserve colloid solutions only for severe or refractory shock that fails to respond to crystalloid therapy.

Initial Fluid Resuscitation

The cornerstone of dengue shock management is judicious fluid replacement, recognizing that dengue shock differs from typical septic shock due to its transient capillary leak syndrome with profound intravascular volume depletion.

First-Line Therapy: Crystalloids

  • Start with isotonic crystalloids (Ringer's lactate or 0.9% saline) as initial resuscitation fluid 1, 2
  • Administer 20 mL/kg boluses over 15-30 minutes 1, 2
  • Reassess after every bolus for signs of improvement or fluid overload 1, 3
  • Either balanced (Ringer's lactate) or unbalanced (normal saline) crystalloids are acceptable, with no significant outcome differences 3

When to Consider Colloids

Colloid solutions should be reserved for specific circumstances 4:

  • Severe dengue shock with pulse pressure <10 mmHg 4
  • Refractory shock not responding to adequate crystalloid resuscitation 5
  • Recurrent shock episodes despite appropriate crystalloid therapy

Important caveat: While colloids (6% hydroxyethyl starch preferred over dextran 70 due to fewer adverse reactions) may reduce recurrent shock episodes, they significantly increase risks of respiratory compromise and need for mechanical ventilation 6, 5. Use colloids only when respiratory support is available 6.

Monitoring and Reassessment

Frequent clinical reassessment is critical to avoid both under-resuscitation and fluid overload:

Signs of Adequate Resuscitation

  • Normal capillary refill time (<3 seconds)
  • Warm, dry extremities with palpable peripheral pulses
  • Improved mental status
  • Urine output ≥0.5 mL/kg/hour (adults) or ≥1 mL/kg/hour (children)
  • Stabilizing or improving hematocrit
  • Mean arterial pressure ≥65 mmHg 7

Signs of Fluid Overload (Stop Further Boluses)

  • Respiratory distress or increased work of breathing
  • Crackles on lung auscultation
  • Hepatomegaly with positive hepatojugular reflux
  • Rising oxygen requirements
  • Worsening oxygenation 3, 6

Vasopressor Support

If shock persists despite adequate fluid resuscitation:

  • First-line vasopressors: Epinephrine or norepinephrine 3
  • Alternative if unavailable: Dopamine (though epinephrine shows better outcomes in resource-limited settings) 3
  • Target MAP: ≥65 mmHg in adults 7
  • Administer through central venous access when possible; if unavailable, use large-bore peripheral IV or intraosseous access with frequent site monitoring for extravasation 4

Critical Pitfalls to Avoid

  1. Excessive crystalloid administration: The 2025 AHA guidelines explicitly note that generalization from dengue shock studies is problematic when applied to other shock states 3. However, dengue-specific evidence shows that overly aggressive fluid resuscitation increases respiratory complications 6.

  2. Prolonged colloid use: Liberal colloid strategies (>4 hours continuous infusion) markedly increase respiratory compromise (OR 8.84) and ventilation requirements (OR 8.16) compared to conservative approaches 6.

  3. Ignoring the critical phase: Dengue shock is characterized by a transient 24-48 hour critical phase of vascular leak. Fluid requirements change dramatically as this phase resolves, necessitating fluid "deresuscitation" to prevent overload 8, 9.

  4. Using dextran 70: When colloids are necessary, 6% hydroxyethyl starch is preferable to dextran 70 due to significantly fewer adverse reactions, despite similar efficacy 5.

Practical Algorithm

  1. Confirm dengue shock: Hypotension with signs of poor perfusion in dengue-confirmed or suspected patient
  2. Initial bolus: 20 mL/kg crystalloid over 15-30 minutes
  3. Reassess at 15-30 minutes: Check perfusion markers and signs of overload
  4. If improved: Transition to maintenance fluids, continue close monitoring
  5. If persistent shock without overload: Repeat 20 mL/kg crystalloid bolus (up to 40-60 mL/kg total in first hour may be needed) 4
  6. If severe/refractory shock: Consider colloid (6% HES) 10-20 mL/kg if respiratory support available 6, 5
  7. If fluid-refractory: Initiate vasopressor support (epinephrine or norepinephrine) 3
  8. Beyond 24-48 hours: As vascular leak resolves, actively reduce fluid administration to prevent overload 8, 9

The evidence strongly supports a conservative, frequently reassessed approach to fluid management in dengue shock, with crystalloids as the foundation and judicious use of colloids only in severe cases with available respiratory support 1, 2, 6, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.